SolveBio is the industry leader in advanced precision medicine data analytics. Its award-winning technology platform enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The core of SolveBio’s platform is technology to connect genomic data that comes from a rapidly compounding complex landscape of vendors, studies, and patients. SolveBio is based in New York and has raised capital from Andreessen Horowitz, Max Levchin, Faridan Ventures, Flatiron Health cofounders Nat Turner and Zach Weinberg, and other leading technology and life sciences investors. SolveBio’s advisory board is made up of George Church, Joel Dudley, Yaniv Erlich, and Stephen Wolfram.